-
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma. Cancer Cell. 2025 Mar 10; 43(3):428-445.e6.
Lubrano S, Cervantes-Villagrana RD, Faraji F, Ramirez S, Sato K, Adame-Garcia SR, Officer A, Arang N, Rigiracciolo DC, Anguiano Quiroz PY, Martini C, Wang Y, Ferguson FM, Bacchiocchi A, Halaban R, Coma S, Holmen SL, Pachter JA, Aplin AE, Gutkind JS. PMID: 40020669; PMCID: PMC11903146.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma. Cancer Lett. 2025 Mar 01; 612:217467.
Sato K, Faraji F, Cervantes-Villagrana RD, Wu X, Koshizuka K, Ishikawa T, Iglesias-Bartolome R, Chen L, Miliani de Marval PL, Gwaltney SL, Adler B, Gutkind JS. PMID: 39826667; PMCID: PMC12044704.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution. Nat Commun. 2025 Jan 08; 16(1):498.
Faraji F, Ramirez SI, Clubb LM, Sato K, Burghi V, Hoang TS, Officer A, Anguiano Quiroz PY, Galloway WMG, Mikulski Z, Medetgul-Ernar K, Marangoni P, Jones KB, Cao Y, Molinolo AA, Kim K, Sakaguchi K, Califano JA, Smith Q, Goren A, Klein OD, Tamayo P, Gutkind JS. PMID: 39779672; PMCID: PMC11711616.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism. Cancer Prev Res (Phila). 2024 Dec 03; 17(12):571-583.
Wu X, Adame-Garcia SR, Koshizuka K, Vo PTT, Hoang TS, Sato K, Izumi H, Goto Y, Allevato MM, Wood KC, Lippman SM, Gutkind JS. PMID: 39463147; PMCID: PMC11969736.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
YAP-Driven Oral Epithelial Stem Cell Malignant Reprogramming at Single Cell Resolution. bioRxiv. 2024 Oct 21.
Faraji F, Ramirez SI, Clubb L, Sato K, Burghi V, Hoang TS, Officer A, Anguiano Quiroz PY, Galloway WM, Mikulski Z, Medetgul-Ernar K, Marangoni P, Jones KB, Molinolo AA, Kim K, Sakaguchi K, Califano JA, Smith Q, Goren A, Klein OD, Tamayo P, Gutkind JS. PMID: 37546810; PMCID: PMC10402053.
View in:
PubMed Mentions:
-
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer Res Commun. 2024 07 01; 4(7):1850-1862.
Goto Y, Koshizuka K, Ando T, Izumi H, Wu X, Sato K, Ishikawa T, Ford K, Feng X, Wang Z, Arang N, Allevato MM, Kishore A, Mali P, Gutkind JS. PMID: 38954773; PMCID: PMC11284272.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2. Sci Rep. 2023 11 10; 13(1):19636.
Komune N, Sato K, Ono M, Imaizumi A, Masuda S, Itoyama S, Manako T, Kuga R, Hongo T, Kogo R, Onishi H, Nakagawa T. PMID: 37949965; PMCID: PMC10638439.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution. Res Sq. 2023 Oct 27.
Gutkind JS, Faraji F, Ramirez S, Clubb L, Sato K, Quiroz PA, Galloway W, Mikulski Z, Hoang T, Medetgul-Ernar K, Marangoni P, Jones K, Officer A, Molinolo A, Kim K, Sakaguchi K, Califano J, Smith Q, Klein O, Tamayo P. PMID: 37961717; PMCID: PMC10635308.
View in:
PubMed Mentions:
1
-
Impact of Positive-Margin Resection of External Auditory Canal Squamous Cell Carcinoma. Cancers (Basel). 2023 Aug 27; 15(17).
Komune N, Kuga R, Hongo T, Kuga D, Sato K, Nakagawa T. PMID: 37686564; PMCID: PMC10486369.
View in:
PubMed Mentions:
-
Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers. Br J Cancer. 2023 10; 129(7):1105-1118.
Kobayashi Y, Niida A, Nagayama S, Saeki K, Haeno H, Takahashi KK, Hayashi S, Ozato Y, Saito H, Hasegawa T, Nakamura H, Tobo T, Kitagawa A, Sato K, Shimizu D, Hirata H, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Mizuno S, Kawazu M, Kohsaka S, Ueno T, Mano H, Ishihara S, Uemura M, Mori M, Doki Y, Eguchi H, Oshima M, Suzuki Y, Shibata T, Mimori K. PMID: 37596408; PMCID: PMC10539316.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma. Br J Cancer. 2023 06; 128(12):2206-2217.
Kitagawa A, Osawa T, Noda M, Kobayashi Y, Aki S, Nakano Y, Saito T, Shimizu D, Komatsu H, Sugaya M, Takahashi J, Kosai K, Takao S, Motomura Y, Sato K, Hu Q, Fujii A, Wakiyama H, Tobo T, Uchida H, Sugimachi K, Shibata K, Utsunomiya T, Kobayashi S, Ishii H, Hasegawa T, Masuda T, Matsui Y, Niida A, Soga T, Suzuki Y, Miyano S, Aburatani H, Doki Y, Eguchi H, Mori M, Nakayama KI, Shimamura T, Shibata T, Mimori K. PMID: 37076565; PMCID: PMC10241955.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Cancer Sci. 2022 Jan; 113(1):156-169.
Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K, Nakagawa T. PMID: 34704338; PMCID: PMC8748226.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansAnimalsCells
-
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Cancer Gene Ther. 2022 05; 29(5):428-436.
Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K. PMID: 34744163.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
Genetic and transcriptomic analyses in a rare case of human papillomavirus-related oropharyngeal squamous-cell carcinoma combined with small-cell carcinoma. Cold Spring Harb Mol Case Stud. 2021 10; 7(5).
Sato K, Nishiyama K, Taguchi K, Jiromaru R, Yamamoto H, Matsunaga A, Nagata R, Rikimaru F, Toh S, Higaki Y, Oda S, Nakagawa T, Masuda M. PMID: 34462366; PMCID: PMC8559619.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. Sci Rep. 2021 09 28; 11(1):19178.
Hu Q, Masuda T, Koike K, Sato K, Tobo T, Kuramitsu S, Kitagawa A, Fujii A, Noda M, Tsuruda Y, Otsu H, Kuroda Y, Ito S, Oki E, Mimori K. PMID: 34584127; PMCID: PMC8478956.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCells
-
Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma? Clin Case Rep. 2021 Sep; 9(9):e04793.
Masuda M, Nagata R, Hara H, Kuroki K, Sato K, Rikimaru F, Toh S, Higaki Y. PMID: 34584700; PMCID: PMC8457411.
View in:
PubMed Mentions:
1
-
Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma. FEBS Open Bio. 2021 Aug; 11(8):2211-2224.
Sekino Y, Imaizumi A, Komune N, Ono M, Sato K, Masuda S, Fujimura A, Koike K, Hongo T, Uchi R, Onishi H, Nakagawa T. PMID: 34115931; PMCID: PMC8329851.
View in:
PubMed Mentions:
2 Fields:
-
Programmed Death-Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Temporal Bone Squamous Cell Carcinoma. Laryngoscope. 2021 12; 131(12):2674-2683.
Hongo T, Kuga R, Miyazaki M, Komune N, Nakano T, Yamamoto H, Koike K, Sato K, Kogo R, Nabeshima K, Oda Y, Nakagawa T. PMID: 34143491.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer. Cancer Sci. 2021 Aug; 112(8):3173-3189.
Kobayashi Y, Masuda T, Fujii A, Shimizu D, Sato K, Kitagawa A, Tobo T, Ozato Y, Saito H, Kuramitsu S, Noda M, Otsu H, Mizushima T, Doki Y, Eguchi H, Mori M, Mimori K. PMID: 34008277; PMCID: PMC8353924.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansAnimalsCells
-
Management of Residual Hearing with Cartilage Conduction Hearing Aid after Lateral Temporal Bone Resection: Our Institutional Experience. Audiol Res. 2021 Jun 09; 11(2):263-274.
Komune N, Higashino Y, Ishikawa K, Tabuki T, Masuda S, Koike K, Hongo T, Sato K, Uchi R, Miyazaki M, Shimamoto R, Tsuchihashi NA, Kogo R, Noda T, Matsumoto N, Nakagawa T. PMID: 34207894; PMCID: PMC8293261.
View in:
PubMed Mentions:
6
-
Auricular complications following temporal bone resection for temporal bone malignancies: A clinical consideration. Clin Otolaryngol. 2021 09; 46(5):1146-1152.
Komune N, Matsuo S, Shimamoto R, Ikemura K, Iwanaga J, Sato K, Yoshida S, Kadota H, Nakagawa T. PMID: 33960128.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer. Cancer Sci. 2021 Apr; 112(4):1655-1668.
Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K. PMID: 33605496; PMCID: PMC8019229.
View in:
PubMed Mentions:
15 Fields:
Translation:
HumansAnimalsCells
-
Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma. J Neurol Surg B Skull Base. 2022 Jun; 83(Suppl 2):e40-e48.
Komune N, Kuga D, Matsuo S, Miyazaki M, Noda T, Sato K, Hongo T, Koike K, Uchi R, Kogo R, Tsuchihashi NA, Masuda S, Nakagawa T. PMID: 35832936; PMCID: PMC9272235.
View in:
PubMed Mentions:
3
-
Prognostic Significance of Systemic Inflammatory Response in Cases of Temporal Bone Squamous Cell Carcinoma. Laryngoscope. 2021 08; 131(8):1782-1789.
Komune N, Sato K, Hongo T, Miyazaki M, Masuda S, Koike K, Uchi R, Tsuchihashi NA, Noda T, Kogo R, Wakasaki T, Yasumatsu R, Nakagawa T. PMID: 33538330.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma. Anticancer Res. 2021 Jan; 41(1):71-79.
Uchi R, Jiromaru R, Yasumatsu R, Yamamoto H, Hongo T, Manako T, Sato K, Hashimoto K, Wakasaki T, Matsuo M, Nakagawa T. PMID: 33419800.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumab. Oral Oncol. 2021 02; 113:105129.
Matsuo M, Yasumatsu R, Masuda M, Toh S, Wakasaki T, Hashimoto K, Uchi R, Jiromaru R, Sato K, Manako T, Nakagawa T. PMID: 33360023.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLoS One. 2020; 15(10):e0241140.
Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K. PMID: 33095806; PMCID: PMC7584171.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Prognostic Impact of Tumor Extension in Patients With Advanced Temporal Bone Squamous Cell Carcinoma. Front Oncol. 2020; 10:1229.
Komune N, Miyazaki M, Sato K, Sagiyama K, Hiwatashi A, Hongo T, Koike K, Noda T, Uchi R, Kogo R, Akagi Tsuchihashi N, Masuda S, Nakagawa T. PMID: 32850367; PMCID: PMC7427636.
View in:
PubMed Mentions:
6
-
Genetic landscape of external auditory canal squamous cell carcinoma. Cancer Sci. 2020 Aug; 111(8):3010-3019.
Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T. PMID: 32500594; PMCID: PMC7419060.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma. Auris Nasus Larynx. 2020 Oct; 47(5):864-869.
Noda T, Komune N, Yasumatsu R, Tsuchihashi NA, Tamae A, Matsumoto N, Sato K, Uchi R, Koike K, Wakasaki T, Tanaka R, Nakagawa T. PMID: 32446629.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma. Anticancer Res. 2020 May; 40(5):2941-2946.
Kidogami S, Iguchi T, Sato K, Yoshikawa Y, Hu Q, Nambara S, Komatsu H, Ueda M, Kuroda Y, Masuda T, Mori M, Doki Y, Mimori K. PMID: 32366446.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Primary Advanced Squamous Cell Carcinoma of the Temporal Bone: A Single-Center Clinical Study. Laryngoscope. 2021 02; 131(2):E583-E589.
Komune N, Noda T, Kogo R, Miyazaki M, Tsuchihashi NA, Hongo T, Koike K, Sato K, Uchi R, Wakasaki T, Matsumoto N, Yasumatsu R, Nakagawa T. PMID: 32267551.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Sci Adv. 2020 03; 6(12):eaay3324.
Omori H, Nishio M, Masuda M, Miyachi Y, Ueda F, Nakano T, Sato K, Mimori K, Taguchi K, Hikasa H, Nishina H, Tashiro H, Kiyono T, Mak TW, Nakao K, Nakagawa T, Maehama T, Suzuki A. PMID: 32206709; PMCID: PMC7080500.
View in:
PubMed Mentions:
56 Fields:
Translation:
HumansAnimals
-
KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma. Cancer Genomics Proteomics. 2020 Mar-Apr; 17(2):141-149.
Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, Hu Q, Kouyama Y, Kobayashi Y, Kuramitsu S, Sato K, Fujii A, Yoshikawa Y, Wakiyama H, Shimizu D, Tsuruda Y, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 32108036; PMCID: PMC7078836.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCells
-
N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study. Int J Mol Sci. 2020 Jan 14; 21(2).
Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K, Fujii A, Hayashi N, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Ohno S, Mimori K, Ueo H. PMID: 31947504; PMCID: PMC7013704.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansCells
-
GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer. Cancer Sci. 2020 Feb; 111(2):343-355.
Nambara S, Masuda T, Kobayashi Y, Sato K, Tobo T, Koike K, Noda M, Ogawa Y, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Mimori K. PMID: 31758608; PMCID: PMC7004548.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCells
-
Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness. J Cancer Res Clin Oncol. 2019 Oct; 145(10):2433-2444.
Omori H, Sato K, Nakano T, Wakasaki T, Toh S, Taguchi K, Nakagawa T, Masuda M. PMID: 31485767.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
-
Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer. Cancer Sci. 2019 Oct; 110(10):3132-3144.
Kouyama Y, Masuda T, Fujii A, Ogawa Y, Sato K, Tobo T, Wakiyama H, Yoshikawa Y, Noda M, Tsuruda Y, Kuroda Y, Eguchi H, Ishida F, Kudo SE, Mimori K. PMID: 31390121; PMCID: PMC6778637.
View in:
PubMed Mentions:
44 Fields:
Translation:
HumansAnimalsCells
-
Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer. EBioMedicine. 2019 Jun; 44:387-402.
Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K. PMID: 31175057; PMCID: PMC6606960.
View in:
PubMed Mentions:
29 Fields:
Translation:
HumansAnimalsCells
-
CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis. Anticancer Res. 2019 Jan; 39(1):99-106.
Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K. PMID: 30591445.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
-
Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors. Cancer Genomics Proteomics. 2019 Jan-Feb; 16(1):21-27.
Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K. PMID: 30587497; PMCID: PMC6348396.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansAnimals
-
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma. Oncology. 2018; 95(3):179-187.
Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K. PMID: 29909415.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer. Ann Surg Oncol. 2018 Mar; 25(3):745-753.
Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K. PMID: 29270876.
View in:
PubMed Mentions:
29 Fields:
Translation:
HumansCells
-
Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer. Oncotarget. 2017 Oct 03; 8(45):78598-78613.
Takano Y, Masuda T, Iinuma H, Yamaguchi R, Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, Iguchi T, Ito S, Eguchi H, Ochiya T, Yanaga K, Miyano S, Mimori K. PMID: 29108252; PMCID: PMC5667985.
View in:
PubMed Mentions:
102 Fields:
-
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer. Anticancer Res. 2017 05; 37(5):2365-2371.
Sato K, Masuda T, Hu Q, Tobo T, Kidogami S, Ogawa Y, Saito T, Nambara S, Komatsu H, Hirata H, Sakimura S, Uchi R, Hayashi N, Iguchi T, Eguchi H, Ito S, Nakagawa T, Mimori K. PMID: 28476802.
View in:
PubMed Mentions:
23 Fields:
Translation:
HumansCells
-
Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma. Anticancer Res. 2017 03; 37(3):1083-1090.
Komatsu H, Masuda T, Iguchi T, Nambara S, Sato K, Hu Q, Hirata H, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 28314268.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCells
-
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis. PLoS One. 2016; 11(11):e0165912.
Iguchi T, Nambara S, Masuda T, Komatsu H, Ueda M, Kidogami S, Ogawa Y, Hu Q, Sato K, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K. PMID: 27824903; PMCID: PMC5100922.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma. Ann Surg Oncol. 2017 Mar; 24(3):850-859.
Komatsu H, Iguchi T, Masuda T, Hirata H, Ueda M, Kidogami S, Ogawa Y, Sato K, Hu Q, Nambara S, Saito T, Sakimura S, Uchi R, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 27770342.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansCells
-
HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma. Anticancer Res. 2016 Jun; 36(6):2767-73.
Komatsu H, Iguchi T, Masuda T, Ueda M, Kidogami S, Ogawa Y, Nambara S, Sato K, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K. PMID: 27272787.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Clinical Significance of Expression of Nephroblastoma Overexpressed (NOV) in Patients with Colorectal Cancer. Anticancer Res. 2015 Dec; 35(12):6591-7.
Ueda M, Iguchi T, Komatsu H, Kidogami S, Hu Q, Sato K, Ogawa Y, Nambara S, Saito T, Sakimura S, Hirata H, Uchi R, Shinden Y, Eguchi H, Ito S, Masuda T, Yamamoto H, Doki Y, Mori M, Mimori K. PMID: 26637874.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansCells